Role of intestinal and salivery microbiota in pulmonary diseases

Role of intestinal and salivery microbiota in pulmonary diseases - Role of intestinal and salivery microbiota in pulmonary diseases

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000035013

Enrollment

150

Registered

2018-11-26

Start date

2018-11-26

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

The patients with pulmonary diseases including lung cancer

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1. Scheduled to receive some treatments for pulmonary diseases. 2. Patients must be aged 20 years or older. 3. Written informed consent is provided by the patient.

Exclusion criteria

Exclusion criteria: None

Design outcomes

Primary

Measure	Time frame
Comprehensive analyses of intestinal and salivery microbiota in the patients with pulmonary diseases including lung cancer	—

Countries

Japan

Contacts

Public ContactTakashi Nojiri

Higashiosaka City Medical Center General Thoracic Surgery

honnnori2003@yahoo.co.jp0667815101

Outcome results